Search by Drug Name or NDC
NDC 44087-1150-01 Ovidrel 250 ug/.5mL Details
Ovidrel 250 ug/.5mL
Ovidrel is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by EMD Serono, Inc.. The primary component is CHORIOGONADOTROPIN ALFA.
Product Information
| NDC | 44087-1150 |
|---|---|
| Product ID | 44087-1150_59d39f88-54fb-480a-979b-4d3d2c7c2cd4 |
| Associated GPIs | 30062022052220 |
| GCN Sequence Number | 053123 |
| GCN Sequence Number Description | choriogonadotropin alfa SYRINGE 250MCG/0.5 SUBCUT |
| HIC3 | P0D |
| HIC3 Description | HUMAN CHORIONIC GONADOTROPIN (HCG) |
| GCN | 20473 |
| HICL Sequence Number | 021868 |
| HICL Sequence Number Description | CHORIOGONADOTROPIN ALFA |
| Brand/Generic | Brand |
| Proprietary Name | Ovidrel |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | choriogonadotropin alfa |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | SUBCUTANEOUS |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | ug/.5mL |
| Substance Name | CHORIOGONADOTROPIN ALFA |
| Labeler Name | EMD Serono, Inc. |
| Pharmaceutical Class | Gonadotropin [EPC], Gonadotropins [CS] |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA021149 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 44087-1150-01 (44087115001)
| NDC Package Code | 44087-1150-1 |
|---|---|
| Billing NDC | 44087115001 |
| Package | 1 SYRINGE, GLASS in 1 CARTON (44087-1150-1) / .5 mL in 1 SYRINGE, GLASS |
| Marketing Start Date | 2003-10-06 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 451.302 |
| Pricing Unit | ML |
| Effective Date | 2024-01-29 |
| NDC Description | OVIDREL 250 MCG/0.5 ML SYRG |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis